Integration, development and win-win future - 2017 member development exchange meeting of medical public credit network mall was held in Chongqing

Source: Chongqing pharmaceutical exchange 2017-12-17 December 16, 2017, the 2017 member development exchange meeting of medicine public credit network mall was held in Radisson Plaza Hotel, Chongqing Song Ruilin, executive chairman of China pharmaceutical innovation promotion association, Liang Hong, Dean of Fudan University Urban Development Research Institute, Wu Zhaohui, director of the comprehensive supervision and Administration Bureau of Zhejiang health and Family Planning Commission, Xu Ligang, director of Sichuan Medical Equipment centralized procurement service center, Beijing Medical centralized procurement service center, Hunan public resources trading center, medical procurement and Property Office, Gansu public resources trading Bureau The relevant directors of the drug purchasing department made wonderful speeches respectively Liu Qingqing, Secretary of the Party committee and chairman of Chongqing pharmaceutical exchange, Ao Rongfeng, general manager, Hu Zeli, deputy general manager, etc attended the meeting, and nearly 600 members of Chongqing pharmaceutical public information network mall attended the meeting Lu Yi, deputy head of Nan'an District People's Government of Chongqing, delivered a speech Hu Zeli, deputy general manager of Chongqing pharmaceutical exchange, delivered a speech He Yang, deputy general manager of Chongqing pharmaceutical public trust network Co., Ltd., presided over the meeting, song Ruilin, executive chairman of China pharmaceutical innovation promotion association, made a speech on the topic of "China pharmaceutical regulatory reform", song Ruilin, executive chairman of China pharmaceutical innovation promotion association, elaborated on the impact of China's pharmaceutical approval system reform on the pharmaceutical industry He believes that the development of China's pharmaceutical industry requires institutional reform to be transformed from two aspects: one is from administrative supervision to scientific supervision; the other is from management center to patient-centered At present, the existing problems are that the approval time of new drugs is too long and the remaining patent period is too short He believes that stable market revenue is the driving force of pharmaceutical innovation To solve this problem, we need to start from two aspects: one is to solve the policy problem, the other is to solve the market problem (song Ruilin, executive chairman of China pharmaceutical innovation promotion association) in addition, he also put forward the idea that China's pharmaceutical innovation industry will become a world power: strengthen system construction to encourage innovation and promote the development of generic pharmaceutical industry; build an ecological environment for innovation of China's pharmaceutical industry to attract global innovative drugs to be listed in China! Liang Hong, Dean of Urban Development Research Institute of Fudan University, made a speech on the topic of "healthy China and medical insurance reform" He believes that the reform of medical insurance in the new era needs to follow the two-wheel drive strategy, that is, medical and health two-wheel drive; medical career and health industry two-wheel drive, medical social security system and commercial insurance two-wheel drive, only in this way can we achieve the effect of reform in the new era At present, there are problems of unbalanced development: urban-rural imbalance - urban-rural integration; regional imbalance - provincial integration, national integration; population imbalance - national security to national security; (Liang Hong, Dean of Urban Development Research Institute, Fudan University) To deal with these problems, we need to carry out supply side reform - the public discourse leading power of medical insurance, limit the scale of public hospitals, establish the planning of designated hospitals and dispensaries for medical insurance, implement the pre insurance of basic medical supply, and improve the service system - the long-term care insurance service system of family doctors' hierarchical diagnosis and treatment, medical consortia and medical support combination; The future medical association must be based on community service, which is the future development direction! Wu Chaohui, member of the pharmaceutical big data purchasing special committee and director of the comprehensive supervision and Administration Bureau of the health and Family Planning Commission of Zhejiang Province, made a speech on the topic of "thinking about the general trend of pharmaceutical purchasing", and Wu Chaohui, member of the pharmaceutical big data purchasing special committee and director of the comprehensive supervision and Administration Bureau of the health and Family Planning Commission of Zhejiang Province, shared the thinking about the general trend of pharmaceutical purchasing (Wu Chaohui, member of the pharmaceutical big data purchasing special committee and director of the comprehensive supervision and Administration Bureau of Zhejiang health and Family Planning Commission) he shared in detail the exploration of Zhejiang medical reform From the practice of Zhejiang Province, we can see the trend of drug centralized purchase Zhejiang adopts the principle of adhering to the direction of centralized purchase, implementing a platform, up-down linkage, open and transparent, classified purchase, taking measures such as the recruitment of production enterprises, the integration of recruitment and purchase, the linking of quantity and price, the double envelope system, and the whole process monitoring, etc to establish a drug concentration that combines the centralized purchase supervision of provincial units with the independent purchase of medical and health institutions New procurement mechanism Compared with the national retail guide price, it decreased by 45.3% in 2009, 12.98% in 2011 and 12.88% in 2014 Xu Ligang, director of Sichuan provincial centralized procurement service center, made a speech on the topic of "five in one" procurement and supervision of medical equipment in Sichuan Province Xu Ligang, director of Sichuan provincial centralized procurement service center, elaborated the procurement and supervision of "five in one" medical equipment from three aspects of "five in one" medical equipment procurement pattern, "five in one" medical equipment procurement supervision, "five in one" medical equipment procurement effect (Xu Ligang, director of the centralized procurement service center of Sichuan Province) in 2015, Sichuan province carried out a round of price limit and network hanging work, with an average decrease of 13%, In 2016, we took measures such as double envelope bidding, price limit by hanging the net, and assessment of sunshine points to continuously reduce the drug price Compared with the price of generic drugs on the net 10 years ago, the average decrease rate was 42%, the maximum decrease rate was 94%, and the number of drugs with a decrease rate of more than 50% accounted for 27% of the total drugs on the net; the drug price was 10.59% lower than that of the previous year, and it is expected that the province can reduce the drug expense Nearly 4 billion yuan Up to now, the total number of drugs on the Internet is 39800, providing reference for the new medical insurance Geng Xiaojun, chief of the Pharmaceutical Department of Beijing Pharmaceutical centralized purchase service center, made a speech on the topic of "Introduction to the pharmaceutical sunshine purchase in Beijing" Geng Xiaojun, chief of the Pharmaceutical Department of Beijing Pharmaceutical centralized purchase service center, introduced the pharmaceutical sunshine purchase in Beijing (Geng Xiaojun, chief of pharmaceutical department, Beijing Pharmaceutical centralized purchasing service center) Since the formal implementation of a new round of comprehensive reform on April 8, 2017, Beijing has successively realized the cancellation of drug mark up, registration fee, diagnosis and treatment fee, the establishment of medical service fee, the implementation of drug sunshine purchase, the standardization of medical service price, the improvement of medical service, the strengthening of cost and expense control, the improvement of hierarchical diagnosis and treatment system, the establishment of financial classification compensation mechanism, the enhancement of medical insurance guarantee and payment mode Reform efforts and other reform tasks Since the reform for eight months, the cost saving of drugs has exceeded the expectation, the price fluctuation of drugs is controllable, many measures are taken simultaneously to ensure the supply of short drugs, the purchase and distribution of commonly used drugs are normal and stable, and the overall evaluation of sunshine purchase meets the reform expectation In the near future, the specific work arrangement of Beijing Municipal Commission of health and family planning is to carry out daily updating of database drugs and relevant information of enterprises, open the process of new warehousing of drugs for record procurement, organize drug price linkage, explore the establishment of enterprise quality and reputation files, and promote the implementation of "two ticket system" in public medical institutions Wang Chaohui, section chief of the medical procurement and property rights office of Hunan public resources trading center, made a speech on the topic of "Introduction to the service functions of the medical procurement system in Hunan Province" Wang Zhaohui, section chief of the pharmaceutical procurement and property right Department of Hunan public resources trading center, has carried out the promotion of the informatization construction of Hunan Province on the aspects of the recent construction of the pharmaceutical procurement platform in Hunan Province, the full electronic transaction of the second kind of vaccine, the "two ticket system" electronic bill verification system of pharmaceutical procurement, the analysis of the inter provincial price linkage mode, and the informatization construction of record procurement Elaboration (Wang Chaohui, section chief of the pharmaceutical purchasing and property right Department of Hunan Public Resources Trading Center) at present, it has realized the tracing management of bill information and purchase order and the "two bill system" bill verification system It establishes the relation information between the invoice of the production enterprise and the accompanying documents, the relation between the first invoice and the inventory of the distribution enterprise, realizes the relation between the purchase order and the invoice of the medical institution, and realizes the comprehensive information management of the warehousing management This is of great significance for other provinces and cities to establish information platform Ma Yongheng, deputy director of pharmaceutical Purchasing Department of Gansu public resources trading Bureau, made a speech on the topic of "brief introduction to pharmaceutical policy and centralized procurement in Gansu Province", and Ma Yongheng, deputy director of pharmaceutical Purchasing Department of Gansu public resources trading Bureau, exchanged views on pharmaceutical policy and centralized procurement in Gansu Province Gansu province implements the drug classification management system, issues all kinds of supply guarantee incentive policies, establishes the detection and early warning mechanism of drug shortage information, strengthens the supervision of online centralized procurement, establishes the provincial drug reserve management system, builds the platform for the exchange and sharing of drug shortage information, implements the online drug record procurement management, establishes the new mode of county rural integrated drug distribution, and implements the drug Dynamic adjustment, construction of drug supply guarantee system, promotion of rational use of drugs, and consolidation of the "shortage of drug supply guarantee" network (MA Yongheng, deputy director of the pharmaceutical procurement department of Gansu public resources trading Bureau) in addition, he introduced the classified procurement with Gansu characteristics Gansu adopts two envelope public bidding to purchase the flying patent drugs with large clinical dosage, high purchase amount and produced by many enterprises Establish an open, transparent and multi-party price negotiation mechanism for patented drugs, exclusively produced drugs, special drugs for serious illness insurance, special drugs for rare diseases, real estate innovative drugs, etc that are not included in the negotiation organized by the state On the basis of provincial economic and technological evaluation, the drugs purchased by the medical institutions such as non patent drugs, emergency (rescue) drugs, drugs with small clinical dosage, basic infusion, commonly used low-cost drugs and drugs not listed in the double envelope of public bidding shall be purchased by the medical institutions sunshine or through the Provincial procurement platform price limit hanging net (author: Zhang Qi)